Persephone Biosciences

Drug Discovery · San Diego, CA · Founded 2017 · Privately Held (backing)

Developer of equitable precision medicines designed to focus on microbial therapeutics for immuno-oncology applications. Persephone Biosciences is based in San Diego, CA and was founded in 2017. It was valued at $37.3 million at its later-stage round in Oct 2024, the last priced event on record. It has raised $21.6 million across 3 recorded rounds; the latest was a $317,000 seed round in Feb 2021.

PMV mark · valuation
$37.3M
Oct 2026
Priced at
its later-stage round
Oct 2024
Total raised
$21.6M
Last round
Seed Round
Feb 2021

Who backs Persephone Biosciences?

31 investors
InvestorType
Y CombinatorOther
Pioneer FundVenture capital
GaingelsVenture capital
Springboard EnterprisesOther
ZhenFundOther
MicroVenturesVenture capital
Susa VenturesVenture capital
Johnson & Johnson Innovation - JLABSOther
Fifty YearsVenture capital
BrightEdgeVenture capital
+ 21 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Persephone Biosciences investors

31 investors are on record for Persephone Biosciences, including Y Combinator, Pioneer Fund, Gaingels and Springboard Enterprises. By type, the record holds 6 venture capital firms. The seed round in Feb 2021 drew 24 investors.

Free account
More of Persephone Biosciences with a free account
  • ·The complete investor list: 31 names
  • ·Watch Persephone Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 31 firms already write checks for companies like Persephone Biosciences in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View